DRKS00021458
Recruiting
Not Applicable
Observational Prospective Clinical Feasibility Study of the MyPal ePRO-based early Palliative Care Digital System in Paediatric Oncology Patients - MyPal4Kids
Centre for Research and Technology Hellas0 sites100 target enrollmentApril 22, 2020
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pediatric Leukemia and solid tumors
- Sponsor
- Centre for Research and Technology Hellas
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria for children:
- •6\-17 years of age
- •Diagnosed with paediatric leukaemia or solid cancer in the past 12 months
- •Receiving anti\-cancer treatment at one of the participating clinical site
- •Have age\-appropriate speaking, reading and comprehension skills in either the German or the Czech language
- •Provide signed \+ informed consent from parents or legal representative and the assent form by all children from the age of 14 years. These documents had been evaluated positively by IEC.
- •Access to an internet connection and mobile device (e.g. smartphone or tablet)
- •Inclusion criteria for parents:
- •Parent(s) with a child eligible for the study, as per the inclusion and exclusion\-criteria
- •Ability to speak, read and understand German or Czech language
Exclusion Criteria
- •Exclusion criteria for children
- •Anyone who is not able to participate in the study according to the clinical judgment of the site chief investigator or any other authorized person of the research team. This judgment has to be documented for each child not being enrolled.
- •Exclusion criteria for parents
- •Anyone who is not able to participate in the study according to the clinical judgment of the site chief investigator or any other authorized person of the research team. This judgment has to be documented for each parent not being enrolled.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Suspended
Not Applicable
An explorative clinical prospective feasibility study to address the effectiveness and safety ofcalciumphosphate/poly(lactic-co-glycolic-acid) for bone augmentation in maxillary sinus floorelevation surgeryMaxillary sinus floor elevation or sinusliftCalcium phosphate cement with poly(lactic-co-glycolic acid) or PLGAMaxillaire sinusbodemelevatie of sinusliftCalciumfosfaat cement met poly(lactic-co-glycolic acid) of PLGANL-OMON25916Radboudumc Tandheelkunde 309, BiomaterialenP.O. Box 91016500 HB Nijmegen11
Completed
Not Applicable
A clinical prospective feasibility study to address the effectiveness and safety of calciumphosphate/poly(lactic-co-glycolic-acid) for bone augmentation in maxillary sinus floor elevation surgery.Alveolar resorptionshrinking of the jaw10005944NL-OMON42402niversitair Medisch Centrum Sint Radboud11
Recruiting
Phase 2
A clinical, prospective feasibility study to assess the effectiveness and safety of micro-structured TCP granules as a bone augmentation material in sinus floor elevation procedures.NL-OMON32900niversitair Medisch Centrum Sint Radboud10
Not yet recruiting
Not Applicable
ROLE OF HOMOEOPATHIC MEDICINE IN DIABETES MELLITUS 2Health Condition 1: E11- Type 2 diabetes mellitusCTRI/2022/01/039691SUNIL THUMAR
Completed
Not Applicable
A Prospective Observational Study of clinical use of Imeglimin for type 2 diabetes mellitusJPRN-UMIN000046316Kyoto University Hospital Department of Diabetes, Endocrinology, and Nutrition30